These observations suggest that activation of IL-6 and p62 in CSC-like EpCAMhigh cells might be an important regulatory axis for CSC-like cell survival and therapeutic resistance in HNSCC. This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.